series-a
Stage
1
Investors
About
Obatala Sciences develops and sells human-derived biomaterials and organ-on-a-chip adipose tissue models (ObaCell, ObaGel) for preclinical research. The company supplies kits, cells, media and contract services for drug screening, biomanufacturing and disease modelling.
Explore Obatala Sciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.